Opportunistic Pulmonary Infections in the Solid Organ Transplant Recipient: A Focus on Drug Therapy.

Megan E Goetz, Rickey A Evans, TrisAnn Rendulic

Critical care nursing quarterly 2017 Oct/Dec

filter terms:

allograft (1)

drug therapies (1)

humans (1)

organ (1)

organ transplant (2)

transplant (1)

virus (1)

Sizes of these terms reflect their relevance to your search.

Immunosuppression required to prevent allograft rejection in the solid organ transplant recipient increases vulnerability to infections. Given continuous environmental exposure, the lungs are increasingly susceptible to bacterial, viral, and fungal opportunistic infections. Drug therapy options for the treatment of opportunistic pulmonary infections are used infrequently. These medications are often classified as high risk with specific administration instructions, as well as a multitude of toxicities. Therefore, in this article, we will discuss select pulmonary opportunistic infections and their associated drug therapies.

Citation

Megan E Goetz, Rickey A Evans, TrisAnn Rendulic. Opportunistic Pulmonary Infections in the Solid Organ Transplant Recipient: A Focus on Drug Therapy. Critical care nursing quarterly. 2017 Oct/Dec;40(4):399-413